Literature DB >> 20006635

Arsenite suppression of involucrin transcription through AP1 promoter sites in cultured human keratinocytes.

Nadezda N Sinitsyna1, Tatiana V Reznikova, Qin Qin, Hyukhwan Song, Marjorie A Phillips, Robert H Rice.   

Abstract

While preserving keratinocyte proliferative ability, arsenite suppresses cellular differentiation markers by preventing utilization of AP1 transcriptional response elements. In present experiments, arsenite had a dramatic effect in electrophoretic mobility supershift analysis of proteins binding to an involucrin promoter AP1 response element. Without arsenite treatment, binding of JunB and Fra1 was readily detected in nuclear extracts from preconfluent cultures and was not detected a week after confluence, while c-Fos was detected only after confluence. By contrast, band shift of nuclear extracts from arsenite treated cultures showed only JunB and Fra1 binding in postconfluent as well as preconfluent cultures. Immunoblotting of cell extracts showed that arsenite treatment prevented the loss of Fra1 and the increase in c-Fos proteins that occurred after confluence in untreated cultures. Chromatin immunoprecipitation assays demonstrated substantial reduction of c-Fos and acetylated histone H3 at the proximal and distal AP1 response elements in the involucrin promoter and of coactivator p300 at the proximal element. Alteration of AP1 transcription factors was also examined in response to treatment with four metal containing compounds (chromate, vanadate, hemin, divalent cadmium) that also suppress involucrin transcription. These agents all influenced transcription at AP1 elements in a transcriptional reporter assay, but exhibited less effect than arsenite on binding activity assessed by mobility shift and chromatin immunoprecipitation and displayed variable effects on AP1 protein levels. These findings help trace a mechanism by which transcriptional effects of arsenite become manifest and help rationalize the unique action of arsenite, compared to the other agents, to preserve proliferative ability. 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20006635      PMCID: PMC2830317          DOI: 10.1016/j.taap.2009.12.006

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  54 in total

Review 1.  The keratinocyte as differentiated cell type.

Authors:  H Green
Journal:  Harvey Lect       Date:  1980

2.  Elevation of cell cycle control proteins during spontaneous immortalization of human keratinocytes.

Authors:  R H Rice; K E Steinmann; L A deGraffenried; Q Qin; N Taylor; R Schlegel
Journal:  Mol Biol Cell       Date:  1993-02       Impact factor: 4.138

3.  Presence in human epidermal cells of a soluble protein precursor of the cross-linked envelope: activation of the cross-linking by calcium ions.

Authors:  R H Rice; H Green
Journal:  Cell       Date:  1979-11       Impact factor: 41.582

4.  Fos-related antigen (Fra-1), junB, and junD activate human involucrin promoter transcription by binding to proximal and distal AP1 sites to mediate phorbol ester effects on promoter activity.

Authors:  J F Welter; J F Crish; C Agarwal; R L Eckert
Journal:  J Biol Chem       Date:  1995-05-26       Impact factor: 5.157

Review 5.  Evidence that arsenite acts as a cocarcinogen in skin cancer.

Authors:  Toby G Rossman; Ahmed N Uddin; Fredric J Burns
Journal:  Toxicol Appl Pharmacol       Date:  2004-08-01       Impact factor: 4.219

6.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

7.  Polycyclic aromatic hydrocarbon mutagenesis of human epidermal keratinocytes in culture.

Authors:  B L Allen-Hoffmann; J G Rheinwald
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

8.  Arsenate perturbation of human keratinocyte differentiation.

Authors:  D J Kachinskas; M A Phillips; Q Qin; J D Stokes; R H Rice
Journal:  Cell Growth Differ       Date:  1994-11

9.  Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous cell carcinomas.

Authors:  J G Rheinwald; M A Beckett
Journal:  Cancer Res       Date:  1981-05       Impact factor: 12.701

10.  Regulation of the human involucrin gene promoter by co-activator proteins.

Authors:  Nhu Q Tran; David L Crowe
Journal:  Biochem J       Date:  2004-07-01       Impact factor: 3.857

View more
  5 in total

1.  Nuclear matrix protein SMAR1 represses c-Fos-mediated HPV18 E6 transcription through alteration of chromatin histone deacetylation.

Authors:  Samik Chakraborty; Kaushik Das; Shilpi Saha; Minakshi Mazumdar; Argha Manna; Sreeparna Chakraborty; Shravanti Mukherjee; Poulami Khan; Arghya Adhikary; Suchismita Mohanty; Samit Chattopadhyay; Subhash C Biswas; Gaurisankar Sa; Tanya Das
Journal:  J Biol Chem       Date:  2014-08-25       Impact factor: 5.157

2.  Interleukin-4 Downregulation of Involucrin Expression in Human Epidermal Keratinocytes Involves Stat6 Sequestration of the Coactivator CREB-Binding Protein.

Authors:  Lei Bao; Jaime B Alexander; Huayi Zhang; Kui Shen; Lawrence S Chan
Journal:  J Interferon Cytokine Res       Date:  2016-02-26       Impact factor: 2.607

Review 3.  Role of the calcium-sensing receptor in calcium regulation of epidermal differentiation and function.

Authors:  Chia-Ling Tu; Daniel D Bikle
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2013-04-12       Impact factor: 4.690

Review 4.  Long-term effects of chromatin remodeling and DNA damage in stem cells induced by environmental and dietary agents.

Authors:  Bhawana Bariar; C Greer Vestal; Christine Richardson
Journal:  J Environ Pathol Toxicol Oncol       Date:  2013       Impact factor: 3.567

5.  Beta-HPV 5 and 8 E6 promote p300 degradation by blocking AKT/p300 association.

Authors:  Heather L Howie; Jennifer I Koop; Joleen Weese; Kristin Robinson; Greg Wipf; Leslie Kim; Denise A Galloway
Journal:  PLoS Pathog       Date:  2011-08-25       Impact factor: 6.823

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.